Visikol Awarded $1.64M NIH NCI Phase II SBIR Award to Further Develop Imaging and Digital Pathology Portfolio
Mike Johnson2021-05-02T06:17:06-05:00Over the last five years, Visikol has developed an extensive portfolio of advanced imaging, digital pathology and cell culture [...]